Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)

U. Gatzemeier, Joachim von Pawel, Jaromı́r Roubec et al.|Journal of Clinical Oncology|2004

Cited by 300